ConductScience.org, home

Trial · NCT02324972

Results by group20

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Change From Baseline in Total Lesion Symptom Score (TLSS)AQX-1125Baseline6.3Standard Deviation 1.16units on a scale
Change From Baseline in Total Lesion Symptom Score (TLSS)PlaceboBaseline6.6Standard Deviation 1.31units on a scale
Change From Baseline in Total Lesion Symptom Score (TLSS)AQX-1125Week 12 (Change from baseline)-1.9Standard Deviation 2.19units on a scale
Change From Baseline in Total Lesion Symptom Score (TLSS)PlaceboWeek 12 (Change from baseline)-1.9Standard Deviation 2.41units on a scale
Change From Baseline in Investigator's Global Assessment (IGA)AQX-1125Baseline2.6Standard Deviation 0.50units on a scale
Change From Baseline in Investigator's Global Assessment (IGA)PlaceboBaseline2.8Standard Deviation 0.52units on a scale
Change From Baseline in Investigator's Global Assessment (IGA)AQX-1125Week 12 (Change from baseline)-0.7Standard Deviation 0.98units on a scale
Change From Baseline in Investigator's Global Assessment (IGA)PlaceboWeek 12 (Change from baseline)-0.8Standard Deviation 0.87units on a scale
Change From Baseline in Eczema Area and Severity Index (EASI) ScoreAQX-1125Baseline5.58Standard Deviation 3.34units on a scale
Change From Baseline in Eczema Area and Severity Index (EASI) ScorePlaceboBaseline5.35Standard Deviation 2.24units on a scale
Change From Baseline in Eczema Area and Severity Index (EASI) ScoreAQX-1125Week 12 (Change from baseline)-2.84Standard Deviation 1.55units on a scale
Change From Baseline in Eczema Area and Severity Index (EASI) ScorePlaceboWeek 12 (Change from baseline)-2.12Standard Deviation 3.19units on a scale
Change From Baseline in Scoring Atopic Dermatitis (SCORAD) ScoreAQX-1125Baseline36.19Standard Deviation 8.70units on a scale
Change From Baseline in Scoring Atopic Dermatitis (SCORAD) ScorePlaceboBaseline37.21Standard Deviation 6.38units on a scale
Change From Baseline in Scoring Atopic Dermatitis (SCORAD) ScoreAQX-1125Week 12 (Change from baseline)-12.06Standard Deviation 11.15units on a scale
Change From Baseline in Scoring Atopic Dermatitis (SCORAD) ScorePlaceboWeek 12 (Change from baseline)-11.54Standard Deviation 11.49units on a scale
Change From Baseline in Patient Oriented Eczema Measure (POEM) ScoreAQX-1125Baseline16.7Standard Deviation 6.98units on a scale
Change From Baseline in Patient Oriented Eczema Measure (POEM) ScorePlaceboBaseline15.9Standard Deviation 5.48units on a scale
Change From Baseline in Patient Oriented Eczema Measure (POEM) ScoreAQX-1125Week 12 (Change from baseline)-5.6Standard Deviation 9.70units on a scale
Change From Baseline in Patient Oriented Eczema Measure (POEM) ScorePlaceboWeek 12 (Change from baseline)-6.5Standard Deviation 5.82units on a scale

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02324972/results